BioCentury
ARTICLE | Company News

AGY licenses stroke compound from M's

July 20, 2004 7:00 AM UTC

M's Science (Kobe, Japan) granted AGY (South San Francisco, Calif.) exclusive rights to develop and commercialize AGY-94806 (SA4503), a small molecule sigma receptor agonist, for certain indications. ...